Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Weight-loss treatments are on the cusp of a revolution, and could benefit large numbers of Indians after the main patent ...

Low testosterone or testosterone deficiency, also known as hypogonadism, is a condition in which patients develop symptoms.

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...

We all react to environmental cues that tell us it’s time to eat, like the scent of fries wafting through the air. These cues ...

The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...